REPAGLINIDE 2 MG TABLET

Repaglinide
$0.0859per EA

Strength

2 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135094890

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

REPAGLINIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078555

On Market Since

1/22/2014

Pharmacological Classes

Glinide
Potassium Channel Antagonists

Price History

1W

0.0%

1M

+0.1%

3M

-8.4%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-5.6%